NCT03675737 2026-02-27KEYNOTE-859Merck Sharp & Dohme LLCPhase 3 Completed1,579 enrolled 31 charts 2 FDA
NCT03615326 2025-12-11MK-3475-811Merck Sharp & Dohme LLCPhase 3 Completed738 enrolled 22 charts 6 FDA